Federico Rotolo

1.4k total citations
32 papers, 781 citations indexed

About

Federico Rotolo is a scholar working on Statistics and Probability, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Federico Rotolo has authored 32 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Statistics and Probability, 10 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Federico Rotolo's work include Statistical Methods in Clinical Trials (13 papers), Statistical Methods and Inference (10 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Federico Rotolo is often cited by papers focused on Statistical Methods in Clinical Trials (13 papers), Statistical Methods and Inference (10 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Federico Rotolo collaborates with scholars based in France, United States and Italy. Federico Rotolo's co-authors include Stefan Michiels, Nils Ternès, Catherine Legrand, Jean‐Pierre Pignon, Jean‐Charles Soria, Lesley Seymour, Xavier Paolettí, Frances A. Shepherd, Ming‐Sound Tsao and Robert A. Kratzke and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Bioinformatics.

In The Last Decade

Federico Rotolo

29 papers receiving 768 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Federico Rotolo France	14	296	207	167	146	141	32	781
Geoffrey Fell United States	15	343 1.2×	118 0.6×	135 0.8×	114 0.8×	161 1.1×	46	862
Nicole Gormley United States	18	362 1.2×	90 0.4×	272 1.6×	131 0.9×	143 1.0×	53	1.0k
Jianchang Lin United States	18	395 1.3×	359 1.7×	293 1.8×	80 0.5×	119 0.8×	84	1.0k
Timothée Olivier Switzerland	15	463 1.6×	341 1.6×	123 0.7×	65 0.4×	119 0.8×	83	873
Rosa Giuliani Italy	15	524 1.8×	128 0.6×	166 1.0×	127 0.9×	155 1.1×	31	805
Judith Fine United States	16	648 2.2×	584 2.8×	184 1.1×	105 0.7×	75 0.5×	24	1.3k
Anil Prasad United States	11	222 0.8×	62 0.3×	465 2.8×	58 0.4×	227 1.6×	18	836
Richard Middleton United Kingdom	11	343 1.2×	520 2.5×	180 1.1×	47 0.3×	115 0.8×	18	1.1k
M N Chang United States	13	263 0.9×	67 0.3×	268 1.6×	84 0.6×	133 0.9×	20	951
Janelle Perkins United States	19	370 1.3×	104 0.5×	160 1.0×	207 1.4×	115 0.8×	67	1.2k

Countries citing papers authored by Federico Rotolo

Since Specialization

Citations

This map shows the geographic impact of Federico Rotolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federico Rotolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federico Rotolo more than expected).

Fields of papers citing papers by Federico Rotolo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federico Rotolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federico Rotolo. The network helps show where Federico Rotolo may publish in the future.

Co-authorship network of co-authors of Federico Rotolo

This figure shows the co-authorship network connecting the top 25 collaborators of Federico Rotolo. A scholar is included among the top collaborators of Federico Rotolo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federico Rotolo. Federico Rotolo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ferrigno, Ana S., Hatem A. Azim, Federico Rotolo, et al.. (2024). Describing quality of life trajectories in young Hispanic women with breast cancer: 5-year results from a large prospective cohort. The Breast. 79. 103866–103866. 1 indexed citations

Azim, Hatem A., Federico Rotolo, Alejandra Platas, et al.. (2024). 303P Predicting quality of life trajectories in young women with breast cancer: 5-year results from a large prospective cohort. Annals of Oncology. 35. S341–S342.

Bin, Riccardo De, et al.. (2023). Favoring the hierarchical constraint in penalized survival models for randomized trials in precision medicine. BMC Bioinformatics. 24(1). 96–96.

Colevas, Dimitrios, Krzysztof Misiukiewicz, Alexander T. Pearson, et al.. (2021). 123MO Monalizumab, cetuximab and durvalumab in first-line treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): A phase II trial. Annals of Oncology. 32. S1432–S1432. 12 indexed citations

Kreitman, Robert J., Claire Dearden, Pier Luigi Zinzani, et al.. (2021). Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial. Journal of Hematology & Oncology. 14(1). 35–35. 56 indexed citations

Michiels, Stefan, et al.. (2019). An alternative trial-level measure for evaluating failure-time surrogate endpoints based on prediction error. Contemporary Clinical Trials Communications. 15. 100402–100402. 1 indexed citations

Stoclin, Annabelle, Federico Rotolo, Élisabeth Chachaty, et al.. (2019). Ventilator-associated pneumonia and bloodstream infections in intensive care unit cancer patients: a retrospective 12-year study on 3388 prospectively monitored patients. Supportive Care in Cancer. 28(1). 193–200. 22 indexed citations

Bagot, M., Pierluigi Porcu, Anne Marie‐Cardine, et al.. (2019). IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial. The Lancet Oncology. 20(8). 1160–1170. 109 indexed citations

Rotolo, Federico, Chang‐Qi Zhu, Élisabeth Brambilla, et al.. (2018). Genome-wide copy number analyses of samples from LACE-Bio project identify novel prognostic and predictive markers in early stage non-small cell lung cancer. Translational Lung Cancer Research. 7(3). 416–427. 10 indexed citations

10.

Texier, Matthieu, Federico Rotolo, Michel Ducreux, et al.. (2018). Evaluation of Treatment Effect with Paired Failure Times in a Single-Arm Phase II Trial in Oncology. Computational and Mathematical Methods in Medicine. 2018. 1–8. 9 indexed citations

11.

Rotolo, Federico, Xavier Paolettí, & Stefan Michiels. (2017). surrosurv: An R package for the evaluation of failure time surrogate endpoints in individual patient data meta-analyses of randomized clinical trials. Computer Methods and Programs in Biomedicine. 155. 189–198. 22 indexed citations

12.

Ternès, Nils, Federico Rotolo, & Stefan Michiels. (2017). biospear: an R package for biomarker selection in penalized Cox regression. Bioinformatics. 34(1). 112–113. 13 indexed citations

13.

Paolettí, Xavier, Federico Rotolo, & Stefan Michiels. (2016). Quelles exigences pour qu'un biomarqueur puisse être un critère de substitution acceptable ?. Bulletin du Cancer. 103(6). S63–S70.

14.

Lueza, B., Federico Rotolo, Julia Bonastre, Jean‐Pierre Pignon, & Stefan Michiels. (2016). Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis. BMC Medical Research Methodology. 16(1). 37–37. 28 indexed citations

15.

Rotolo, Federico, Jean‐Pierre Pignon, Sophie Marguet, et al.. (2016). Surrogate endpoints for overall survival in loco-regionally advanced nasopharyngeal carcinoma: Results from the individual patient data meta-analysis MAC-NPC2. Annals of Oncology. 27. vi328–vi328. 1 indexed citations

16.

Michiels, Stefan, Nils Ternès, & Federico Rotolo. (2016). Statistical controversies in clinical research: prognostic gene signatures are not (yet) useful in clinical practice. Annals of Oncology. 27(12). 2160–2167. 28 indexed citations

17.

Rotolo, Federico, Ariane Dunant, Thierry Le Chevalier, Jean‐Pierre Pignon, & R. Arriagada. (2014). Adjuvant cisplatin-based chemotherapy in nonsmall-cell lung cancer: new insights into the effect on failure type via a multistate approach. Annals of Oncology. 25(11). 2162–2166. 24 indexed citations

18.

Rotolo, Federico & Stefan Michiels. (2014). Testing the treatment effect on competing causes of death in oncology clinical trials. BMC Medical Research Methodology. 14(1). 72–72. 7 indexed citations

19.

Rotolo, Federico, et al.. (2012). parfm: Parametric Frailty Models in R. SHILAP Revista de lepidopterología. 7 indexed citations

20.

Rotolo, Federico, Catherine Legrand, & Ingrid Van Keilegom. (2012). A simulation procedure based on copulas to generate clustered multi-state survival data. Computer Methods and Programs in Biomedicine. 109(3). 305–312. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact